Gaca Z

Department of Clinical Research and Development, LUXMED Group, Warsaw, Poland.

4 papers

ArticleKetamine

Lessons learned from the regulatory alignment in ketamine, esketamine and arketamine clinical trials: A cross-sectional analysis of protocols from ClinicalTrials.gov.

Swieczkowski D, Kwaśny A, Sadko K +4

Europe PMC2025
ArticlePsilocybin

Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysis.

Swieczkowski D, Kwaśny A, Pruc M +3

Europe PMC2025
ArticlePsilocybin

Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis.

Swieczkowski D, Kwaśny A, Pruc M +3

Europe PMC2025
ArticlePsilocybin

Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials.

Swieczkowski D, Kwaśny A, Pruc M +3

Europe PMC2025